DPDPE

(4S,7S,13S)-13-[(2S)-2-AMINO-3-(4-HYDROXYPHENYL)PROPANAMIDO]-7-BENZYL-3,3,14,14-TETRAMETHYL-6,9,12-TRIOXO-1,2-DITHIA-5,8,11-TRIAZACYCLOTETRADECANE-4-CARBOXYLIC ACID

(4S,7S,13S)-7-Benzyl-3,3,14,14-tetramethyl-6,9,12-trioxo-13-(L-tyrosylamino)-1,2-dithia-5,8,11-triazacyclotetradecan-4-carbonsäure

(4S,7S,13S)-7-Benzyl-3,3,14,14-tetramethyl-6,9,12-trioxo-13-(L-tyrosylamino)-1,2-dithia-5,8,11-triazacyclotetradecane-4-carboxylic acid

1,2-Dithia-5,8,11-triazacyclotetradecane-4-carboxylic acid, 13-[[(2S)-2-amino-3-(4-hydroxyphenyl)-1-oxopropyl]amino]-3,3,14,14-tetramethyl-6,9,12-trioxo-7-(phenylmethyl)-, (4S,7S,13S)-

88373-73-3

Acide (4S,7S,13S)-7-benzyl-3,3,14,14-tétraméthyl-6,9,12-trioxo-13-(L-tyrosylamino)-1,2-dithia-5,8,11-triazacyclotétradécane-4-carboxylique

DPDPE

MFCD00076430

(4S,7S,13S)-13-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)-7-benzyl-3,3,14,14-tetramethyl-6,9,12-trioxo-1,2-dithia-5,8,11-triazacyclotetradecane-4-carboxylic acid

(4S,7S,13S)-13-[(S)-2-amino-3-(4-hydroxy-phenyl)-propionylamino]-7-benzyl-3,3,14,14-tetramethyl-6,9,12-trioxo-1,2-dithia-5,8,11-triaza-cyclotetradecane-4-carboxylic acid

(4S,7S,13S)-13-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3,3,14,14-tetramethyl-6,9,12-trioxo-7-(phenylmethyl)-1,2-dithia-5,8,11-triazacyclotetradecane-4-carboxylic acid

(D-Pen(2),D-pen(5))enkephalin

(D-Pen2,D-Pen5)-Enkephalin

(D-Pen2,Pen5)-Enkephalin

13-[2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-7-benzyl-3,3,14,14-tetramethyl-6,9,12-trioxo-1,2-dithia-5,8,11-triaza-cyclotetradecane-4-carboxylic acid

2,5-Pen-enkephalin

6-[2-amino-1-hydroxy-3-(4-hydroxy-2,6-dimethylphenyl)butylamino]-12-benzyl-2,2,5,5-tetramethyl-7,10,13-trioxo-3,4-dithia-8,11,14-triazacyclotetradecane-1-carboxylic acid

88373-72-2

88381-29-7

[2-D-Penicillamine, 5-D-penicillamine]enkephalin

[D-Pen(2)-D-Pen(5)]-enkephaline

[D-Pen2, D-Pen5]enkephalin

[D-PEN2,5]-ENKEPHALIN

[D-Pen2,5]Enkephalin

[D-Pen2,D-Pen5]enkephalin

[D-Pen2-D-Pen5]-enkephaline

[tyrosyl-2,6-3H(N)]-(2-D-penicillamine, 5-D-penicillamine) enkephalin

A0A0H4AWC7_DUGDU

A0A0V1DID4_TRIBR

Bis-pen-enkephalin

Bis-penicillamine-enkephalin

c[D-Pen(2,5)]-enkephalin

Cannabinoid receptor 1

Cyclic [D-Pen2, D-Pen5]enkephalin

Cyclic(D-penicillamine2,5)enkephalin

cyclo-[D-Pen(2,5)]-enkephalin

cyclo-[D-Pen2,5]-enkephalin

D-penicillamine (2,5)-enkephalin

D-penicillamine-(2,5)-enkephalin

D-Valine, L-tyrosyl-3-mercapto-D-valylglycyl-L-phenylalanyl-3- mercapto-, cyclic (2-5)-disulfide

D-Valine, L-tyrosyl-3-mercapto-D-valylglycyl-L-phenylalanyl-3-mercapto-, cyclic (2-5)-disulfide

Dpdpe(SH)2

DPLPE

Enkephalin, pen(2,5)-

Enkephalin, penicillamine(2,5)-

H-Tyr-c(D-Pen-Gly-Phe-D-Pen)-OH

H-Tyr-cyclo-(D-Pen-Gly-Phe-D-Pen)-OH

H-Tyr-D-Pen-Gly-Phe-D-Pen-OH

L-tyrosyl-3-mercapto-D-valylglycyl-L-phenylalanyl-3-mercapto-D-valine, cyclic (2-5)-disulfide

Neuropeptides B/W receptor type 1

Norepinephrine transporter

NPBW1_HUMAN

OPRD_HUMAN

OPRD_MOUSE

OPRD_PIG

OPRD_RAT

OPRK_CAVPO

OPRK_HUMAN

OPRK_RAT

OPRM_CAVPO

OPRM_HUMAN

OPRM_MOUSE

OPRM_RAT

Pen(2),pen(5)-enkephalin

Q9JIA2_RAT

SC6A4_RAT

Sodium-dependent serotonin transporter

Tyr-D-Pen-Gly-Phe-D-Pen [Disulfide Bridge: 2-5]

Δ-type opioid receptor

κ-type opioid receptor

μ-type opioid receptor